Alcon (ALC) Total Debt Growth (1y) (2010 - 2026)
Powered by 
Analysis
Alcon (ALC) Total Debt Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 12.29% |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | -1.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.07% |
| Mar 31, 2026 | 11,977.14% |
| Dec 31, 2025 | -8.29% |
| Sep 30, 2025 | -9.97% |
| Jun 30, 2025 | 2.15% |
| Mar 24, 2025 | 74.64% |
| Dec 31, 2024 | -1.84% |
| Sep 30, 2024 | 2.37% |
| Jun 30, 2024 | 4,611.11% |
| Mar 31, 2024 | -53.33% |
| Dec 31, 2023 | 4,865.98% |
| Sep 30, 2023 | 5,746.25% |
| Jun 30, 2023 | -15.12% |
| Mar 31, 2023 | 24.37% |
| Dec 31, 2022 | -102.51% |
| Sep 30, 2022 | 39.39% |
| Jun 30, 2022 | 34.85% |
| Mar 31, 2022 | 8.46% |
| Dec 31, 2021 | 2,482.10% |
| Sep 30, 2021 | -104.00% |